Who is sponsoring NCT01302483?

NCT01302483 is sponsored by St. Renatus, LLC.

What condition does NCT01302483 study?

NCT01302483 studies Dental Anesthesia Efficacy.

What drugs are being tested in NCT01302483?

Interventions: 3% tetracaine HCL with 0.05% oxymetazoline HCL, Lidocaine Injection.

What is the status of NCT01302483?

NCT01302483 is currently COMPLETED.

Last reviewed 2015-06-16 · How we verify

A Phase II, Single-Center, Randomized, Double-Blind, Active-Treatment-Controlled, Parallel-Group Study of the Efficacy of Kovacaine Nasal Spray for Anesthetizing Maxillary Teeth in Healthy Dental Patients

NCT01302483 Phase 2 COMPLETED Results posted

The purpose of this study was to determine the safety and efficacy of Kovacaine Mist (3% tetracaine HCl with 0.05% oxymetazoline HCl) for anesthesia of the maxillary teeth for dental procedures.

Details

Lead sponsor	St. Renatus, LLC
Phase	Phase 2
Status	COMPLETED
Enrolment	45
Start date	2008-12
Completion	2009-01

Conditions

Dental Anesthesia Efficacy

Interventions

3% tetracaine HCL with 0.05% oxymetazoline HCL
Lidocaine Injection

Primary outcomes

Pulpal Anesthesia — Continuous throughout dental treatment period (up to 60 minutes)
Number of participants who did not need rescue anesthesia to complete the study dental procedure, i.e. Kovacaine provided enough pulpal anesthesia to complete a dental procedure.

Countries

United States